The peptide problem: Hype is outrunning the evidence Peptides are surging in popularity. There's little evidence that they work. FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York